FDA Health Claims Initiative On Crawford’s Priority List
This article was originally published in The Tan Sheet
FDA's revised approach to regulating health claims for dietary supplements and foods has an advocate in acting commissioner-designate Lester Crawford, PhD
You may also be interested in...
Although qualified health claims are a step in the right direction for FDA and industry, they may not help nutritional manufacturers sell their products, according to a Nestle executive
FDA Commissioner Mark McClellan, MD/PhD, is leaving FDA before the agency makes a decision on whether Barr Labs' Plan B (levenorgestrel .75 mg) is approvable for over-the-counter use
FDA expects to release its qualified health claims proposed rule this fall, pending review of public comments and agency-sponsored label comprehension research